First Time Loading...

Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 17.11 USD -0.58%
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

1.3B
+18%
Assets
Growth Rates:
1 Year
+3%
3 Years
+38%
5 Years
+400%
7 Years
-
10 Years
-
586m
-7%
Liabilities
Growth Rates:
1 Year
-10%
3 Years
+117%
5 Years
+1 484%
7 Years
-
10 Years
-
707m
+53%
Equity
Growth Rates:
1 Year
+18%
3 Years
+6%
5 Years
+219%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Arcus Biosciences Inc

1.3B
Assets
586m
Liabilities
1.3B
Assets
586m
Liabilities
Current Assets 1.1B
Cash & Short-Term Investments 995m
Receivables 40m
Other Current Assets 29m
Non-Current Assets 229m
Long-Term Investments 100m
PP&E 51m
Other Non-Current Assets 78m
Current Liabilities 204m
Accounts Payable 16m
Accrued Liabilities 64m
Other Current Liabilities 124m
Non-Current Liabilities 382m
Other Non-Current Liabilities 382m

Balance Sheet
Arcus Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
65
98
71
58
173
148
206
127
Cash Equivalents
65
98
71
58
173
148
206
127
Short-Term Investments
34
77
186
130
555
351
803
632
Total Receivables
0
0
0
0
2
747
39
42
Accounts Receivables
0
0
0
0
2
747
39
42
Other Receivables
0
0
0
0
0
0
0
0
Other Current Assets
0
1
2
4
6
16
19
30
Total Current Assets
100
177
259
193
736
1 262
1 067
831
PP&E Net
9
11
11
9
24
137
135
143
PP&E Gross
9
11
11
9
24
137
135
143
Accumulated Depreciation
1
4
8
11
14
18
23
31
Long-Term Investments
1
1
4
0
6
182
129
107
Other Long-Term Assets
0
2
1
1
6
11
14
14
Total Assets
110
N/A
191
+74%
275
+44%
203
-26%
772
+280%
1 592
+106%
1 345
-16%
1 095
-19%
Liabilities
Accounts Payable
4
4
3
5
16
10
20
17
Accrued Liabilities
1
3
6
10
31
52
76
76
Short-Term Debt
0
0
0
0
0
0
0
0
Other Current Liabilities
1
6
8
9
75
104
97
91
Total Current Liabilities
6
13
17
23
122
166
193
184
Long-Term Debt
0
0
0
0
0
0
0
0
Other Liabilities
5
24
23
17
148
584
495
449
Total Liabilities
10
N/A
37
+259%
40
+9%
39
-2%
270
+587%
750
+178%
688
-8%
633
-8%
Equity
Common Stock
120
226
0
0
0
0
1 206
1 311
Retained Earnings
20
73
123
205
328
275
542
849
Additional Paid In Capital
0
1
358
369
830
1 118
0
0
Other Equity
0
0
0
0
0
1
7
0
Total Equity
100
N/A
154
+55%
235
+53%
164
-30%
502
+207%
842
+68%
657
-22%
462
-30%
Total Liabilities & Equity
110
N/A
191
+74%
275
+44%
203
-26%
772
+280%
1 592
+106%
1 345
-16%
1 095
-19%
Shares Outstanding
Common Shares Outstanding
42
42
45
46
65
71
73
76

See Also

Summary
RCUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
RCUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RCUS stock valuation using valuation multiples.
Wall Street Estimates
RCUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RCUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.